To include your compound in the COVID-19 Resource Center, submit it here.

Infergen interferon alfacon-1: Marketed

In a study of 266 HCV-infected patients who had

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE